Hepatitis Viruses - part 1 Flashcards

HAV, HBV, HEV

1
Q

Viral hepatitis - types

A

HAV, HBV, HCV, HDV, HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hepatitis as a complication

A
  • Yellow fever, CMV, EBV, HSV

- Entero, Rubela, Adeno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hepatitis A common name

A

Infectious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Naked, RNA, picornavirus is the virus structure of ?

A

Hepatitis A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Transmission - Hep A

A

Fecal-oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Incubation period - Hep A

A

Short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Usual onset - Hep A

A

Abrupt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mild or asymptomatic severity for which virus?

A

Hep A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Very low mortality rate for which virus?

A

Hep A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronicity/carrier state for Hep A?

A

None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hep A has other disease associations (T/F)

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The common name for Hepatitis B is serum (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Virus structure for Hep B

A

Envelope, DNA, hepadnavirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The transmission of Hep B is fecal oral (T/F)

A

False; parenteral and sexual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Incubation period - Hep B

A

Long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The usual onset of Hep B is?

A

Insidious (gradual)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The severity of Hep B is occasionally severe (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mortality rate - Hep B

A

Low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Presence of chronicity/Carrier state - Hep B

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hep B has other disease associations which are?

A

HCC, Cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HCC - explain

A

Hepatocellular carcinoma - primary liver cancer

In chronic infection for Hepatitis, the virus continues to replicate in liver cells causing continued immune response leading to cell death.
Since the liver regenerates, mitosis occurs consistently.
Also due to cell death, scar tissue forms leading to high chance for cirrhosis.
With higher rates of mitosis, replication must occur more often and this leads to higher chances of mutations = cellular dysplasia (abnormal development of cells+tissues) causing HCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hepatitis C common name

A

Posttransfusion non A, non B

(Hepatitis was found in some persons receiving blood transfusions; HepA is rare to contract from post transfusion and Hep B is usually asymptomatic. Cases of non A, non B Hepatitis is referred to as Hep C)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Incubation period of Hep C is short (T/F)

A

False; it is long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Usual onset of Hep C is abrupt (T/F)

A

False; it is insidious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Subclinical - define

A

relating to or denoting a disease which is not severe enough to present definite or readily observable symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Severity of Hep C is usually subclinical (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Mortality rate for Hep B and Hep C is low (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Chronicity/carrier states are common in Hep C (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

HCC and Cirrhosis are other disease associations of Hep B and Hep C (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Hepatitis D - common name is Delta (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Hep D causes symptoms only in people who also have hepatitis B infection (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Transmission of Hep B,C and D are all parenteral and sexual

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Incubation period - Hep D

A

Intermediate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Onset of Hep D is?

A

Abrupt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Occasionally to often severe - severity of Hep D (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Mild severity but severe in pregnant women is the severity of which Hepatitis virus?

A

Hepatitis E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Mortality rate of Hep D is?

A

High to very high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Chronicity/ carrier state for Hep D exists?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Fulminant hepatitis - define

A

Severe liver function impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Cirrhosis, fulminant hepatitis are the disease associations of which hepatitis virus?

A

Hepatitis D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Enteric - define

A

Illness occurring in intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Hepatitis E common name

A

Enteric non A, non B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Envelope RNA, flavivirus - which hep virus structure?

A

Hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Envelope RNA - which hep virus structure?

A

Hep D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Naked RNA, calici like - which hep virus structure?

A

Hep E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Hep A and Hep E transmission is by fecal oral route (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Incubation period Hep E

A

Short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Incubation period for Hep A and Hep E

A

Short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Usual onset of Hep E

A

Abrupt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Usual onset of Hep A, Hep D, Hep E

A

Abrupt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Hepatitis E mortality rate is low except for which demographic?

A

Pregnant women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

There is no carrier state in Hep E (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Hep E - disease associations

A

None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Icosahedral symmetry, non-enveloped - which virus?

A

Hep A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

How many serotypes of Hep A are there?

A

One

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Types of cell cultures for Hep A

A

Human & simian (ape) cell cultures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

How to inactivate hep A

A

Inactivated by boiling in 1 minute, formalin, chlorine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Whole virus particle

A

Vaccine is made using the entire virus particle, this is usually done by heating
Antibody - anti HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Virus shedding of Hep A is done by

A

Feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Communicability - Hep A

A

2 weeks before to 1 week after onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Risk factors - Hep A

A

Poor personal hygiene & Overcrowding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Prognosis for Hep A is usually good (T/F)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Hepatitis virus pathogenesis

A
  1. Entry- mouth
  2. Viral multiplies in intestinal epithelium
    ssRNA - HAV, HCV, HDV, HEV
    pdsDNA (partially ds) - HBV
  3. Reaches its destination i.e. liver by haematogenous spread where it multiplies
    Enters cell via endocytosis
    Synthesize proteins via ribosomes (+)
    RNA dep RNA polymerase synthesizes more RNA
    HBV
    Endocytosis
    Uncoating - release envelope + antigens
    DNA repair enzymes finish the double strand (e.g. if it’s 75% finished)
    mRNA made to make proteins e.g. capsomeres
    Pregenomic RNA - Hep B is type of retrovirus
    Reverse transcriptase converts RNA -> ssDNA then partial dsDNA forms
    – Can potentially become incorporated into genome and viral replication will occur infinitely
    Lysis of hepatocyte = cell death
  4. Liver cell death due to immune response
    Infecteded cell secreted IFN-gamma which activates macrophages which activates CD8T cells
    CTLs recognize antigen on MHC I of nucleated liver cell
    Perforins - cause holes to form in liver cells
    Granzymes - enter through holes inducing apoptosis/programmed cell death
  5. Brief viremia (presence of virus in blood)
  6. Fever + malaise presentation
    Cytokines produced by damaged liver cells
    IL-1, IL-6, TNF-alpha
    These cytokines stimulate hypothalmus to cause fever
  7. Nausea + vomiting
    Toxins (hepatotoxins) accumulate in blood and go to CNS
    Chemotrigger zone sensitive to hepatotoxins
    Chemotrigger sends signal to ammetic center
    Ammetic centre activates nerves in GIT = retroperistalsis (vomiting/reverse peristalsis)
    Can also have diarrhoea
    - Low electrolytes , weight loss
  8. Icterus, Jaundice, Dark Urine
    Hemoglobin -> Heme -> Biluribin (unconjugated) -UCB
    UB taken to liver to be converted to conjugated bilurubin (CB)
    Liver cells are lysing so UCB and CB spill out of liver cells and into blood
    Bile acids accumulate in blood also due to blockage
    Conc’n of UCB, CB, bile acids are high in blood so moves to diff tissues ( Yellow Eye - sclera = icterus, Palms + Soles yellow colour = jaundice )
    CB in urine because kidneys filter CB but large increase will cause dark urine
  9. Clay coloured stools - icteric phase
    Bile is broken down by bact in gut so decreased bile due to failed liver = decreased bilurubin in gut. Product of broken down bilurubin = brown colour of stools
    So stools will be clay coloured instead.
  10. Hepatomegaly - icteric phase
    Right upper quadrant abd pain
  11. Virus present in blood and feces 10 -12 days after infection
  12. Virus excretion in feces-During late Icteric Phase (affected by jaundice) and Preicteric (before jaundice) Phase

For HBV, HCV
— Plasma cells produce antibodies against Hep virus
– Antibodies bind to virus forming a complex which deposits into tissues
E.g. in synovial joints – Arthritis
in BV – vasculitis
In pericardium + myocardium – Myocarditis + pericarditis
In glomurela basement of kidney – glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the most common cause of acute hepatitis in children ?

A

Hep A

65
Q

What are the stages of Hep A?

A

1) Prodromal or Preicteric- flu like symptoms
Onset - Abrupt :- Acute or insidious - fever, malaise, anorexia, nausea, vomiting

2) Icteric - Jaundice, acolic stools, liver tenderness/hepatomegaly

3) Convalescent phase - Acute infection only
- Flu like symptoms going away, not much jaundice, hepatomegaly going away

66
Q

Recovery time - Hep A

A

4-6 weeks - slow

67
Q

Hepatitis A signs and symptoms

A

Fever, Jaundice (yellow eyes, yellow tinge to skin), pain/tenderness in upper abdomen, urine dark yellow/brown, feces pale

68
Q

Anti-HAV IgM (IgM antibody to hepatitis A)

A

Indicates current or recent infection with hepatitis A.

IgM anti-HAV is usually present 5-10 days before symptom onset and declines to undetectable levels within six months of initial infection.

69
Q

When should someone order the Anti-HAV IgM test?

A

This is the test that should be ordered for a patient who is suspected of having acute hepatitis A.

70
Q

Anti-HAV IgG (IgG antibody to hepatitis A) test shows?

A

Indicates immunity to hepatitis A, either from past infection or vaccination.

71
Q

Anti-HAV IgG test is not recommended post vaccination, why?

A

Vaccine generally induces a very good immune response and immunity after vaccination can be assumed.

72
Q

HAV IgM and IgG; total anti-HAV (IgM and IgG antibody to hepatitis A)

A

Occasionally, the laboratory reports the IgG and IgM together.
Primarily used to determine exposure to HAV either naturally or due to vaccination.
Anti HAV levels will rise from month of exposure consistently past 12 months

73
Q

Is the total anti-HAV test informative? Why or why not?

A

This result is not informative, as it does not allow you to determine if this is an acute infection or if the patient is immune to hepatitis A.

74
Q

Specimen for hep A

A

Feces, blood

75
Q

Visualization of Hep A

A

IEM ( Immune Electron Microscopy ) , IF ( Immuno Florouscence )

76
Q

HAV Ag detection

A

ELISA

77
Q

HAV serology

A

IgM anti-HAV Antibodies by ELISA ,

RIA ( appear during acute phase & disappear within 3 – 6 months .
—[ Elevated liver enzymes and serum bilirubin level ].

78
Q

Pooled human Immunoglobulin (Ig)

A

Human immunoglobulin preparations are pooled from plasma from normal blood donors.
It contains antibodies to hepatitis A, measles, mumps, varicella, polio .

79
Q

Live attenuated vaccine

A

Used to protect people who have been exposed to virus (post-exposure) or otherwise may be exposed to the virus (pre-exposure).

This vaccine works by exposing you to a small dose of the virus, which causes the body to develop immunity to the disease.

80
Q

Inactive vs Live vaccines

A

Inactivated vaccine (or killed vaccine) - consists of virus particles grown in culture and killed to destroy disease producing capacity.

Live vaccines - use pathogens that are still alive (but are almost always attenuated/ weakened)

81
Q

Why are some vaccines inactivated?

A

Pathogens are grown under controlled conditions and are killed to:
- prevent infection from the vaccine

82
Q

Classification of inactivated vaccines by method of inactivation

A

Whole virus vaccines - use the entire virus particle, fully destroyed using heat, chemicals, or radiation.

Split virus vaccines - using a detergent to disrupt the virus.

Subunit vaccines - produced by purifying antigens that best stimulate the immune system to mount a response to the virus, while removing other components necessary for the virus to replicate or survive or that can cause adverse reactions

83
Q

Why are booster shots necessary for inactivated vaccines?

A

Inactivated viruses produce a weaker response by the immune system than live viruses

Multiple “booster” injections provide an effective immune response against the pathogen

84
Q

Which demographic may be more suitable for inactivated vaccines?

A

Some people cannot take attenuated vaccines because the pathogen poses too much risk for them

E.g. elderly people or people with immunodeficiency

85
Q

Prevention - HAV

A

Improved sanitary practices

Prevention of fecal contamination of food and water

Passive –pooled normal human Ig IM

Formaldehyde inactivated vaccine – prepared from human fetal lung fibroblast cell lines –IM.

Live attenuated vaccine –prepared from human diploid cell line ( China ).

86
Q

HAV vaccines - list

A

Formalin inactivated whole virus

HAVRIX (GlaxoSmithKline)

(Two I.M. injections)

Protection from 4 weeks, upto 20 yrs

87
Q

Immunogenic - define

A

Producing long lasting immunity

88
Q

Hepatitis E Virus genome

A

ss+ve RNA genome

89
Q

Labile - define

A

Easily broken down/displaced

90
Q

HEV is mainly transmitted via water contamination with feces with minimal person-person transmission (T/F)

A

True

91
Q

HEV epidemics reported in

A

India , Asia , Africa & Central America

92
Q

Serology sequence in HEV

A
  1. After an incubation period ranging from 15 to 60 days, HEV-infected patients develop symptoms of hepatitis with appearance of anti-HEV IgM antibody in serum
    (Viral shedding in stool from weeks 3-8)
  2. This is followed by detectable anti-HEV IgG within a few days.
  3. Anti-HEV IgM may remain detectable up to 6 months after onset of symptoms, while anti-HEV IgG usually persists for many years after infection.
  4. Anti-HEV IgM is the serologic marker of choice for diagnosis of acute HEV infection.
93
Q

HEV visualization

A

Electron Microscopy-

94
Q

Specimen

A

Feces & bile in Icteric Phase or Acute phase of illness.

95
Q

Molecular testing - HEV

A

HEV RNA ( by reverse transcriptase PCR ) in stool and serum of infected patients

96
Q

HEV serology

A

Anti-HEV antibody : IgM & IgG ( Serum antibody detection by ELISA ).

97
Q

HEV - prevention

A

Avoid drinking water (and beverages with ice) of unknown purity, uncooked shellfish, and uncooked fruit / vegetables not peeled or prepared by traveler.

No Vaccine is available for prevention of HEV

98
Q

Hepatitis E Virus ( Non A non B enteric transmitted hepatitis ) infection responds well to treatment with immunoglobulin (T/F)

A

False. Hepatitis E Virus ( Non A non B enteric transmitted hepatitis ) infection responds poorly to treatment with immunoglobulin .

99
Q

HBV - features

A

DNA virus, icosahedral symmetry, core circular (HBc = core protein), enveloped, surface protein (HBs)

100
Q

HBV - morphological forms

A

Three morphological forms-

1) 22 nm size Spherical forms
2) 22 nm size Filamentous forms
3) 42 nm size Dane particle forms

101
Q

HBV serotypes seen in which countries?

A

ADW serotype - Europe , Australia & America

ADR , AYW ,AYR - Asian countries

102
Q

Inner nucleocapsid consists of which antigen?

A

HBcAg-Antigen expressed on the core ( Core antigen )

103
Q

Capsid vs nucleocapsid

A

Capsid - protein coat surrounding nucleic acid of the virus particle
Nucleocapsid - capsid together with the nucleic acids of a virus

104
Q

HBeAg in HBV

A

Soluble nonparticulate nucleocapsid protein ( Hepatitis B e antigen )

105
Q

Serologic tests were developed in 1980s (T/F)

A

False. Serologic tests were developed in 1970s

106
Q

Humans are the only known host of HBV (T/F)

A

True

107
Q

Risk factors -HBV

A

Multiple partners (23%)
Injection Drug Use (20%)
Men who have sex with men (17%)
Household (3%)

108
Q

HBV - complications

A

Fulminant hepatitis -1 %, Cirrhosis

Extra hepatic complications – arthralgia (joint pain), urticarial (hives), rarely polyarteritis (BV inflammation damaging organs), glomerulonephritis (filtering sys of kidney - glomeruli damaged).

Hepatocellular carcinoma (primary liver cancer)

109
Q

Carrier stage -Two types

A

1) Super carriers - high HBsAg (10^13/ ml of blood), positive HBeAg, DNA polymerase, HBV (10^8/ml) in circulation
2) Simple carriers - low HBsAg, negative HBeAg, DNA polymerase, HBV

110
Q

HBV has higher risk of carrier in neonate (T/F)

A

True

111
Q

Specimen HBV

A

Serum, Liver biopsy

112
Q

HBV visualization

A

EM, IEM

113
Q

HBV Serological markers

A

Antigens: HBsAg
HBeAg

Antibodies: Anti-HBc- IgM & IgG
Anti-HBs
Anti-HBe

114
Q

HBsAg or Surface antigen (hepatitis B surface antigen):

what does this test indicate?

A

Indicates either acute hepatitis B infection or, more often, a carrier of hepatitis B. These individuals are infectious to others.

Patients who are HBsAg positive require follow-up testing, which includes IgM anti-HBc, HBeAg, anti-HBe and serum transaminases, to determine appropriate clinical management.

115
Q

What demographic should HBsAg test be conducted for?

A

This is the test that should be ordered for prenatal screening.

116
Q

If a mother is HBsAg positive, what action should be taken with regards to the baby?

A

Babies born to mothers who are HBsAg positive require - hepatitis B Immune Globulin (HBIG) and
- hepatitis B vaccine series beginning at birth

117
Q

Anti-HBs or HBsAb or surface antibody (antibody to hepatitis B surface antigen):
What does this test indicate?

A

Indicates immunity to hepatitis B, from either exposure to the virus or from vaccination.

118
Q

Anti-HBs are always present with HBsAg (T/F)

A

False; Anti-HBs will usually not be present with HBsAg.

119
Q

Anti-HBs is the test that should be ordered to assess whether the vaccine has been effective (T/F)

A

True

120
Q

What measurement of titre indicates protection against HBV?

A

A titre of greater than or equal to 10 IU/L indicates protection against hepatitis B.

121
Q

Anti-HBc or IgG anti-HBc or HBcAb or Core antibody

(IgG antibody to hepatitis B core antigen):

What does this test indicate?

A

Indicates that the person either has or had hepatitis B.

Anti-HBc does not tell you whether the patient is still infectious (HBsAg positive) or whether they have developed immunity to the virus (anti-HBs positive) since anti-HBc will be present in both conditions.

122
Q

When does the Core antibody/Anti-HBc develop?

A
  • Develops after exposure to the hepatitis B virus and persists for many years.
123
Q

Anti-HBc does not develop after immunization with hepatitis B vaccine (T/F)

A

True

124
Q

What does HBsAg positive test result mean?

A

Patient is infectious

125
Q

What does anti-HBs positive test result mean?

A

Patient has immunity to virus

126
Q

Anti-HBc does not tell you whether the patient is still infectious or whether they have developed immunity to the virus, why is that?

A

Anti-HBc is present in both conditions

127
Q

IgM anti-HBc or anti-HBc IgM

(IgM antibody to hepatitis B core antigen):

What does this test indicate?

A

Indicates acute or recent infection with hepatitis B.

128
Q

When should an IgM anti-HBc test be ordered? And should any additional tests be ordered as well?

A

This is the test that should be ordered (along with HBsAg) when acute hepatitis B is suspected.

129
Q

This marker usually disappears within 3 weeks of initial infection (T/F)

A

False; This marker usually disappears within six months of initial infection.

130
Q

HBeAg (Hepatitis B e antigen):

What does this test indicate?

A

HBeAg indicates a person who is highly infectious to others.

131
Q

HbeAg will only be present in a person who is also HBsAg positive (T/F)

A

True

132
Q

When does HbeAg appear in patients and how long does it persist?

A

HBeAg appears in the acute stage of infection and in some patients will persist for decades.

133
Q

Anti-HBe (Antibody to hepatitis B e antigen):

What does this test indicate?

A

Indicates a person who was HBeAg positive but has developed immunity to this antigen.

134
Q

If a person is HBsAg positive, what does this mean in terms of infectivity to others compared with being HbeAg positive?

A

If they are still HBsAg positive then they are still infectious to others but less infectious than when they were also HBeAg positive.

135
Q

What is an immunoglobulin test?

A
  • measures the level of types of antibodies in the blood.
136
Q

The body makes different antibodies, or immunoglobulins, to fight different things (T/F)

A

True. For example, the antibody for chickenpox isn’t the same as the antibody for mononucleosis.

137
Q

Types of antibodies - list

A

Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Immunoglobulin E, Immunoglobulin D

138
Q

IgA - is found where?

A

It’s found in the linings of the respiratory tract and digestive system, as well as in saliva (spit), tears, and breast milk.

139
Q

IgG is the most common antibody (T/F)

A

True

140
Q

IgG is found where? When does IgG form in terms of immune response?

A

It’s in blood and other body fluids.

IgG can take time to form after an infection or immunization.

141
Q

Where is IgM found and when does it appear in immune response?

A

Found mainly in blood and lymph fluid

First antibody to appear in the response to initial exposure to an antigen.

142
Q

Where is IgE found normally in small amounts?

In what scenario would there be high amounts of IgE?

A

Normally found in small amounts in the blood.

Higher amounts when the body overreacts to allergens or is fighting an infection from a parasite.

143
Q

IgD is found where?

A

Only small amounts in the blood.

144
Q

What is the interpretation of the foll results?

HBsAg HBeAg Anti-HBc Anti-HBs Anti-HBe
+ + IgM - -

A

Acute HBV infection ; highly infectious

145
Q

What is the interpretation of the foll results?

HBsAg HBeAg Anti-HBc Anti-HBs Anti-HBe
+ + IgG - -

A

Late / chronic inf. or carrier ; highly infectious

146
Q

What is the interpretation of the foll results?

HBsAg HBeAg Anti-HBc Anti-HBs Anti-HBe
+ - IgG - +/-

A

Late/chronic inf. or carrier ; low infectivity

147
Q

What is the interpretation of the foll results?

HBsAg HBeAg Anti-HBc Anti-HBs Anti-HBe
- +/- IgM - +/-

A

Rarely in early Acute inf. ; infectious

148
Q

What is the interpretation of the foll results?

HBsAg HBeAg Anti-HBc Anti-HBs Anti-HBe
- - IgG +/- +/-

A

Remote inf. ; infectivity nil / very low

149
Q

Remote infection - define

A

Infection that still carries some risk of reactivation

150
Q

What is the interpretation of the foll results?

HBsAg HBeAg Anti-HBc Anti-HBs Anti-HBe
- - - + -

A

Vaccination

151
Q

Treatment options for HBV for chronic, carrier and general

A

No specific antiviral treatment
Chronic hepatitis - Interferon alpha

                              Lamivudine

                              Famcyclovir Carrier state - no specific treatment
152
Q

Prevention of HBV

A

Prevent perinatal HBV transmission

Routine vaccination of all infants

Vaccination of children in high-risk groups

Vaccination of adolescents

Vaccination of adults in high-risk groups

153
Q

Composition of HBV vaccine is?

A

Recombinant HBsAg

154
Q

Efficacy of HBV vaccine

A

95% (Range :- 80% -100%)

155
Q

Duration of immunity in HBV vaccine

A

> 15 years

156
Q

Schedule for HBV vaccine

A

3 Doses IM (intramuscular) - 0,1 & 6 months

157
Q

Booster doses not routinely recommended for HBV vaccine (T/F)

A

True

158
Q

Recipients for HBV vaccine

A

Persons diagnosed with an STD
Injection drug users
Inmates of long-term correctional facilities
Persons receiving hemodialysis
Healthcare workers
Persons travelling to areas of high endemicity
Recipients of certain blood products